您使用提示模式 关闭

HELX - Franklin Genomic Advancements ETF (USD) (US35473P5200)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
US35473P5200
HELX ISIN
交易所交易基金 (ETF)
基金类型
Franklin Templeton Investments
提供商
35,73 USD
每股资产净值 | 2026-06-04
2020-02-25
成立日期
1 每年的次数
股息的支付
CEOJLS
CFI
HELX
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
Russell 3000 Index
基准
0.5 %
总成本比率
23,22 百万 USD
基金资产总量 | 2026-06-04
23,22 百万 USD
股票类资产 | 2026-06-04
否
UCITS

收益率 在 2026-06-04, Cboe BZX Exchange

  • YTD
    -10,83 %
  • 1M
    -6,62 %
  • 3M
    -7,6 %
  • 6M
    -7,55 %
  • 1Y
    24,21 %
  • 3Y
    9 %
  • 5Y
    -21,11 %
  • 10Y
    -
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (HELX)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

HELX profile

The Franklin Genomic Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Franklin Templeton Investments fund’s base currency is USD and the share class was registered 25.02.2020 with unique ISIN - US35473P5200. Main exchange is Cboe BZX Exchange and ticker symbol is HELX. The total expense ratio is 0.5%. The Franklin Genomic Advancements ETF (USD) pays dividends 1 time(s) per year.

结构 HELX 在 2026-06-03

下载结构至 Excel 文档
证券 值
GUARDANT HEALTH INC GH 8,86%
NATERA INC NTRA 6,71%
KRYSTAL BIOTECH INC KRYS 5,92%
UNITED THERAPEUTICS CORP UTHR 4,1%
LIGAND PHARMACEUTICALS LGND 3,95%
BRIDGEBIO PHARMA INC BBIO 3,54%
ADAPTIVE BIOTECHNOLOGIES ADPT 3,42%
ELI LILLY & CO LLY 3,06%
ASTRAZENECA PLC AZN 2,89%
INSMED INC INSM 2,73%
VERTEX PHARMACEUTICALS IN VRTX 2,73%
SAMSUNG BIOLOGICS CO LTD 207940 2,61%
CORTEVA INC CTVA 2,38%
TWIST BIOSCIENCE CORP TWST 2,31%
CASH — 2,28%
ALNYLAM PHARMACEUTICALS I ALNY 2,19%
TRAVERE THERAPEUTICS INC TVTX 2,16%
MEDPACE HOLDINGS INC MEDP 2,11%
NEUROCRINE BIOSCIENCES IN NBIX 2,08%
REGENERON PHARMACEUTICALS REGN 2,06%
IONIS PHARMACEUTICALS INC IONS 2,05%
TEMPUS AI INC-CL A TEM 1,84%
ARGENX SE ARGX 1,65%
VERACYTE INC VCYT 1,57%
BIONTECH SE-ADR BNTX 1,52%
PTC THERAPEUTICS INC PTCT 1,42%
STOKE THERAPEUTICS INC STOK 1,38%
CADENCE DESIGN SYS INC CDNS 1,22%
CHARLES RIVER LABORATORIE CRL 1,15%
GRAIL INC GRAL 1,12%
CRISPR THERAPEUTICS AG CRSP 1,08%
SARTORIUS AG-VORZUG SRT3 1,06%
REPLIGEN CORP RGEN 1,01%
BEAM THERAPEUTICS INC BEAM 0,92%
ANAPTYSBIO INC ANAB 0,91%
AXSOME THERAPEUTICS INC AXSM 0,9%
CATALYST PHARMACEUTICALS CPRX 0,89%
JAZZ PHARMACEUTICALS PLC JAZZ 0,86%
PRAXIS PRECISION MEDICINE PRAX 0,83%
THERMO FISHER SCIENTIFIC TMO 0,82%
IQVIA HOLDINGS INC IQV 0,81%
CAREDX INC CDNA 0,74%
AGILENT TECHNOLOGIES INC A 0,69%
DANAHER CORP DHR 0,62%
HINGE HEALTH INC-A HNGE 0,57%
QIAGEN N.V. — 0,51%
SAMSUNG EPISHOLDINGS CO L 0126Z0 0,48%
ULTRAGENYX PHARMACEUTICAL RARE 0,47%
ARCUTIS BIOTHERAPEUTICS I ARQT 0,39%
RHYTHM PHARMACEUTICALS IN RYTM 0,37%
BIO-RAD LABORATORIES-A BIO 0,31%
KINIKSA PHARMACEUTICALS I KNSA 0,29%
TARSUS PHARMACEUTICALS IN TARS 0,28%
BRISTOL-MYERS SQUIBB CO BMY 0,27%
BEONE MEDICINES LTD-ADR ONC 0,26%
NEUROGENE INC NGNE 0,21%
FIRST TRACKS BIOTHERAPEUT TRAX 0,18%
GENEDX HOLDINGS CORP WGS 0,13%
WAVE LIFE SCIENCES LTD WVE 0,11%
RECURSION PHARMACEUTICALS RXRX 0,08%
OMNIAB INC - 15.00 EARNOU 2200964 0%
OMNIAB INC - 12.5 EARNOUT 2200963 0%
Net Current Assets — -0,04%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权